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‘Non-Mendelian’ genetics of fetal growth
D. Fradin1, P. Boileau1, J. Lepercq2, and P. Bougnères1
1Department of Pediatric Endocrinology; 2Department of Gynecology and Obstetrics,
Hôpital Saint Vincent de Paul, Paris, France
ABSTRACT. Mendelian genetics showed that dis-
rupted imprinting genes can lead to phenotypic 
changes in pre-natal growth. It is likely that genetic 
determinants of fetal size may be found in imprinted 
genes. Mendelian genetics, however, is somewhat 
limited in its ability to explain the individual vari-
ability of size at birth within the ‘normal’ range. 
Fetal growth is a complex multifactorial, multigenic 
trait comprised of various ‘sub-traits’, such as body 
mass, fat and muscle, brain mass, head circumfer-
ence, spine and limb skeletal growth. It is likely that 
different genetic factors and genomic variants are 
responsible for the variations of these ‘sub-traits’, 
however this hypothesis needs to be tested. A study 
has been initiated to test the assumption that non-
Mendelian genetics plays a role in the variation of 
human birth weight. The ultimate aim is the identifi-
cation of genomic variations that are within or near 
certain selected candidate genes and are associated 
with variations of human height at birth.
[J. Endocrinol. Invest. 28 (Suppl. to no. ?): ???-???, 2005]
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MENDELIAN GENETICS OF FETAL GROWTH
Mendelian genetics, ie the genetics of monogenic 
diseases, have become an important field of pedi-
atric endocrinology. The restriction of fetal growth 
offers examples of Mendelian diseases (small size 
for gestational age with monogenic causes). To in-
duce pathological manifestations, mutations have 
to alter a gene product necessary to a function or 
a pathway which is itself necessary to allow normal 
fetal growth. The alteration of the gene product 
is generally qualitative (a truncated or a function-
ally deficient protein), more rarely quantitative (a 
markedly reduced expression of the protein of in-
terest). Nonsense or missense mutations located 
within exons or the deletion of useful exons can 
result in abnormal proteins that have lost most, 
if not all of their function. Promoter mutations or 
epimutations modifying DNA methylation can 
result in decreased expression of the protein. 
Understandably, evolution has tried to eliminate 
disabling mutations as ‘errors of nature’. For this 
reason, most monogenic diseases and their causa-
tive mutations are rare. Monogenic disorders can 
sometimes be mimicked by the experimental ma-
nipulation of the gene of interest, by altering its 
RNA or protein products in a knock-out or knock-
in mouse, or in a cell line. 
GENETIC VARIATION OF FETAL GROWTH THAT 
IS DEPENDENT ON IMPRINTING
Genomic imprinting is an epigenetic process that 
marks the parental origin of certain genes. Imprint-
ing results in the monoallelic expression of a gene, 
at least for a given time (intrauterine life for example) 
and in a given tissue. The monoallelic expression de-
pends on the parental origin of the allele. Genes that 
are not expressed from the maternal allele are said 
to be maternally imprinted (ie, maternally imprinted 
genes are those whose paternal allele is expressed 
alone). For most genes following the rules of Mende-
lian genetics character transmission, the parental ori-
gin of genetic information has no influence on gene 
expression. In contrast, genomic imprinting follows 
the rules of ‘parent-specific gene expression’. Most 
imprinted genes are found clustered with other im-
printed genes. This clustering of imprintable genes 
is likely to have functional consequences that are not 
yet understood. As many of the known imprinted 
genes are involved in the control of fetal growth, ge-
nomic imprinting might be a key component of the 
mechanisms underlying maternal constraint, which 
limits fetal size in order to allow vaginal delivery. 
The first observation of an imprinted gene was 
obtained by the knockout of the Igf2 gene by ho-
mologous recombination in mice (1). Fetal growth 
was reduced if the inactivated allele was transmit-
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ted paternally, but normal when the maternal allele 
was mutated. Conversely, maternal inheritance of a 
non-functional Igf2r gene results in fetal overgrowth, 
whereas paternal transmission of the disrupted allele 
leads to normal fetal size (2). Recently, Constancia et 
al. (3) have mutated the placenta-specific promoter 
of Igf2 gene and their results were comparable to 
the complete knockout of Igf2 gene (3). Newborn 
mice with a paternal copy of the mutated promoter 
showed comparable growth retardation to mice 
with a complete disruption of the Igf2 gene. This 
indicates that a paternally expressed (maternally 
imprinted) gene in the placenta acts as a regulator 
of mouse fetal growth. This example shows that im-
printed genes imply a differential role for maternally 
vs paternally derived genetic information, and may 
have different consequences on placental function. 
Knockouts of the paternally expressed Igf2, Peg1 
and insulin genes result in fetal growth restriction, 
whereas knockout of the maternally expressed Igf2r 
gene results in fetal overgrowth. These results sup-
port the prediction that paternally expressed (mater-
nally silenced) genes enhance fetal growth, whereas 
maternally expressed (paternally silenced) genes 
act as growth inhibitors (4). It is fascinating that the 
maternal environment (nutrition, climate, light, work-
load, etc) could be perceived by the pregnant moth-
er’s body and generate signals that induce chemical 
modifications of parts of the fetal genome which are 
involved in regulation of fetal growth (5).
In humans, fetal growth restriction can result from 
alterations in expression of imprinted genes. A major 
cluster of imprinted genes occurs at chromosome 
11p15. This cluster contains IGF-2 and H19 genes, 
which are reciprocally imprinted, and several genes 
which are under the control of a differentially meth-
ylated CpG island (KvDMR1). Molecular defects 
affecting these genes are involved in the Beckwith-
Wiedemann syndrome (BWS). BWS is a syndrome of 
pre-natal overgrowth with macroglossia, hypoglyc-
emia and visceromegaly. Paternal uniparental disomy 
for 11p15 is found in 20% of BWS patients (6). In addi-
tion, the bi-allelic expression of IGF2 has been associ-
ated with somatic overgrowth in children having no 
other features of BWS (7). More recently, an epimuta-
tion has been described in some patients with Silver-
Russell syndrome (SRS) (8). SRS is a syndrome of pre-
natal growth retardation with body asymmetry and a 
small triangular facies. A demethylation (epimutation) 
was identified in the imprinting centre region ICR1 of 
this 11p15 region. This demethylation is responsible 
for the biallelic expression of H19 and the downregu-
lation of IGF-2 expression that probably results from a 
relaxation of imprinting. Ten percent of patients with 
BWS have a hypermethylation of the H19 promoter 
(9). This molecular mechanism is the opposite of 
the epimutation described in SRS patients. These 
observations suggest that paternally expressed and 
maternally silenced IGF-2 is an important regulator of 
human fetal growth. 
The effect of genomic imprinting is the expression 
of only one copy of a gene during fetal growth. This 
form of gene control allows the other gene copy to 
remain available eitherfor critical periods of rapid 
post-natal growth or for functioning during tissue 
maturation. The predominant theory for genomic 
imprinting is known as the ‘parental conflict theory’, 
which focuses on the nutritional needs of the fetus 
that are met by the mother via the placenta (10). This 
theory leads to the prediction that imprinted growth 
enhancers will be silent in maternal derived alleles 
whereas imprinted growth inhibitors will be silent 
in paternal derived alleles. This theory has been 
successful at explaining the imprinting of pater-
nally expressed enhancers (IGF-2, KCNQ1OT1) and 
maternally expressed inhibitors (Igf2r, CDKN1C) of 
pre-natal growth. 
Because disrupted imprinting genes can lead to 
phenotypic changes in pre-natal growth, it is likely 
that genetic determinants of fetal size may be found 
in imprinted genes. It is suspected that genomic vari-
ants located within imprinted genes will be identified 
as one of the mechanisms underlying fetal growth 
variation. However, low birth weight children have 
higher mortality not only soon after birth but also 
later on in their adult life. Therefore, it is important to 
keep in mind that imprinting, although not the only 
mechanism involved in epigenetic processes, could 
also interact with the programming phenomena that 
link fetal life to post-natal environmental conditions. 
Changes in expression of imprinted genes could also 
provide a genetic link between intrauterine growth 
and the programming of fetal systems involved in 
the long-term risk of metabolic disease in adult-
hood, notably in the field of insulin resistance.
NON-MENDELIAN GENETICS
Non-Mendelian genetics belong to a different world. 
They deal mostly with the question of how genomic 
variations contribute to individual differences, ie the 
phenotypic variation. In case of quantitative traits, 
people cannot be categorized as ‘cases’ or ‘controls’, 
they are human individuals with phenotypic variabil-
ity. The extensive polymorphism of the human ge-
nome, which results in varying protein isoforms and 
varying protein quantities in various tissues explains 
much of the variation of each human trait. Humans 
do not have, for instance, the same birth weight, 
adult height, glucose level, blood pressure, muscle 
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or fat mass. They owe these differences in part to the 
physical and cultural environment in which they live, 
but also to their specific genomic constitution, which 
is different in every individual. The human genome 
contains approximately 10 million single nucleotide 
polymorphisms (SNPs), each of them with two alle-
les generating three genotypes (or diplotypes). The 
10 millions single nucleotide polymorphisms of the 
human genome could in theory generate 310.000.000 
combinations of diplotypes. This number is however 
a gross overestimation of human genomic diversity 
because many SNPs are linked to each other on the 
same DNA strand, with their alleles being inherited 
as unrecombined blocks, generating what is called 
linkage disequilibrium between these alleles.
FETAL GROWTH: A MULTIFACTORIAL 
MULTIGENIC TRAIT
Fetal growth is without doubt a complex trait (Fig. 1), 
with a partial genetic determination itself regulated by 
many genes. The existence of many genes important 
to fetal growth is demonstrated by the vast number 
of chromosomal abnormalities that are capable of im-
pairing fetal growth severely. A fraction of the genes 
regulating fetal growth has functional SNPs (coding 
or regulatory). Functionally important SNPs or their 
variants can also be located outside of genes in the 
intergenic non coding DNA portions of the genome. 
Whether they are coding, interfering with splicing, 
or regulating gene expression, functional genomic 
SNPs should not be considered as deleterious muta-
tions. There is no disease here, no ‘errors of nature’, 
only the natural variation of fetal growth. Nature has 
used genomic SNPs to shape and transmit a degree 
of diversity of fetal growth across individuals. To be 
expected to play a significant role in fetal growth at 
the population level, a SNP needs (a) to affect the trait 
in a quantitatively sufficient manner (affect size), and 
(b) to be present in a rather large fraction of people, 
ie, its allelic frequency should exceed 0.10-0.20. To 
be frequent in the modern human population, a 
SNP has to be ancient, and retained and expanded 
throughout human history (possibly because it has 
been useful in a given environment). It is likely that 
fetal growth has been the subject of genetic selec-
tion during evolution, because of its importance for 
survival. Birth is clearly a critical moment of life, maybe 
the most critical. The perinatal period is characterized 
by the highest mortality risk that a human being has 
to face during his entire life. Size at birth seems to play 
a major role, as smaller or larger than normal babies 
have increased mortality. Evolution has stabilized hu-
man birth size within relatively narrow limits in order to 
reduce perinatal mortality. There is however a degree 
of interindividual variability. Genes important for the 
physiology of fetal growth can certainly be unravelled 
in animal models, at least for the part of physiology 
that is not species specific. In contrast, animal models 
are unlikely to tell us which human SNPs are important 
to shape the variations of human fetal size, because 
these SNPs are human. Genomic variants that de-
termine the variations of fetal growth can only be 
searched for in humans. Reimplanting them through 
genetic manipulations in mice to demonstrate their 
precise physiology will be difficult, because the pen-
etrance of their expression will have to go through the 
mice background (both genetic and environmental).
FETAL GROWTH, A PHENOTYPE MADE 
OF SEVERAL PARTS
Genetics studies the relationships of genes (or SNPs 
located outside genes) with a given phenotype. Fe-
tal growth is not a simple homogeneous phenotype. 
The fetus is made of several components that are 
likely to have their own genetics. The quantitative 
trait, referred to as fetal size, measured at birth in g 
and cm, has to be dissected in several ‘sub-traits’ or 
components: body mass including all organs, fat and 
Fig. 1 - From genes to complex traits.
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muscle, brain mass, head circumference (a large part 
of body length), spine and limb skeletal growth. It is 
likely that different genetic factors and genomic vari-
ants are responsible for the variations of these ‘sub-
traits’. For example, gene polymorphisms that are 
important for the variation of skeletal growth in utero 
may have little to do with the storage of lipid calo-
ries, an important component (20%) of birth weight. 
HOW MANY GENES ARE EXPECTED TO BE 
IMPORTANT FOR VARIATIONS IN FETAL SIZE?
Fetal growth is a multifactorial phenomenon that is 
dependent on the maternal environment and on a 
panoply of fetal genes. But only a fraction of these 
genes are subjected to variation, ie, those which 
carry functional SNPs interfering with growth re-
lated physiology. The heritability of birth weight and 
height is around 0.50, indicating a significant role of 
genetic factors (11). It is yet impossible to know how 
many genes are involved in the variation of these 
traits. For a long time, geneticists have thought that 
complex traits follow the ‘infinitesimal model’ which 
proposes that a large number of genes (hundreds), 
each playing a minuscule role (<1/100th of the over-
all variance), are involved in trait variation. It seems 
more plausible today that even very complex traits 
have an oligogenic control involving a few ‘major’ 
variants (12), each of them accounting for 5-10% 
of the variance of the trait. There are no indications 
yet of the number of variant alleles determining the 
natural variations of fetal growth in any mammal.
A GENETIC APPROACH OF FETAL HEIGHT
In a recent study, our group obtained birth height 
measurements from hundreds of children born 
at term to Caucasian European women after un-
eventful gestations and deliveries. Birth height was 
considered as a quantitative parameter following a 
continuous distribution (Fig. 2). Based on classical 
genetic data and evaluation of heritability around 
0.50, it was hypothesized that ‘non-Mendelian’ ge-
netics were playing a role in the variation of human 
birth height. 
There were two options to identify the genes and 
variants that play a role in the individual variation of 
birth height. The first one is to list genes known for 
their role in the physiology of human fetal growth 
(or mammalian fetal growth) and to find the known 
SNPs within or near these genes using data bases 
or sequencing of these regions. These SNPs could 
a priori be suspected to be functional genomic vari-
ants (Gf) important to growth of fetal skeleton or to 
be closely linked as markers (Gm) to the functional 
SNPs (Gf). Finally the statistical association of fetal 
size with these SNPs, or blocks of SNPs (haplotypes) 
can be tested. 
A second option is to have no a priori hypothesis re-
garding genes responsible for the skeletal growth of 
human fetuses, and to engage in a ‘blind’ genome-
wide approach. This requires the use of genomic 
markers (Gm), hundreds of microsatellites or tens or 
hundreds of thousands of anonymous SNPs scattered 
on the whole human genome. Hundreds of pairs of 
siblings are needed for this purpose. The phenotypic 
variation of fetal height can be modelled as the in-
tra-pair difference between the birth heights of two 
siblings, then tested against the similarity of genomic 
variation at given polymorphic sites on the genome 
(microsatellites or SNPs) of the two siblings. 
Our study group decided to follow the first scenario, 
which requires the study of 400 microsatellites span-
ning the whole genome. At each microsatellite site, 
the studied siblings share 0, 1 or 2 alleles identical 
by descent from their parents. A variance compo-
Fig. 2 - Fetal size dissected in its compo-
nents. Genes that have no variant allele 
associated with variation of fetal size, 
but are nevertheless important to the 
determination of fetal size are in open 
circles. Genes that have functional vari-
ants influencing the variation of fetal size 
are shown as closed circles, with those 
having a marked influence on fetal size 
displayed as larger circles. Gaussian 
curves are shown to indicate that quanti-
tative traits each have their own variation 
distribution.
1
Fetal size
Body
weight
Environment
Muscle
mass
Body
height
Head
circumference Fat
massBrain
mass
Tissues,
organsSpine
length
Limb
length
Genes
Ready for press
Return by Fax to n°
02.48.20.12.19
Signature ...................................................................
Ready for press
Return by Fax to n°
02.48.20.12.19
Signature ...................................................................
4D. Fradin, P. Boileau, J. Lepercq, et al. Non-Mendelian genetics of fetal growth
5
nent method can be used to study the relationship 
between the intra-pair sharing of microsatellite alleles 
and the observed intra-pair difference of birth height. 
Using this approach, we found that two chromosomal 
regions displayed a high probability of being associ-
ated with birth height variation. These regions can be 
considered as ‘fetal height quantitative trait locus’ 
(QTL). Because these regions are very large (3-10 Mb) 
and contain hundreds of potential candidate genes, a 
fine-mapping approach has to be used. This method 
uses a dense collection of genomic markers in the 
regions which we previously identified as QTL. Fine 
mapping will keep the candidate genes to a manage-
able number. These genes will then be tested. The 
ultimate aim is the identification of genomic variations 
[QTNs: quantitative trait nucleotides(QTN)] which are 
within or near these genes, and which are associated 
with variations of human height at birth. 
CONCLUSIONS
Scientific evidence generated from Mendelian ge-
netic studies can explain to some extent the genetic 
origins of certain growth related disorders. It is docu-
mented that fetal growth restrictions can result from 
alterations in expression of imprinted genes and 
that the major cluster of such genes occur at chro-
mosome 11p15. Non-Mendelian genetics, however, 
seems to be more capable of explaining phenotypic 
variability. Fetal growth is a complex multifacto-
rial, multigenic trait. This is also suggested by the 
large number of chromosomal abnormalities which 
play a role in impaired fetal growth. Evolution has 
stabilized human birth size within relatively narrow 
limits in order to reduce perinatal mortality, but with 
a degree of individual variability. The quantitative 
trait of fetal size is comprised of several ‘sub-traits’ or 
components: body mass including all organs, fat and 
muscle, brain mass, head circumference, spine and 
limb skeletal growth. It is likely that different genetic 
factors and genomic variants are responsible for the 
variations of these ‘sub-traits’. A study has been 
initiated by our group to test the hypothesis that 
non-Mendelian genetics plays a role in the variation 
of human birth weight. The ultimate aim is the identi-
fication of genomic variations that are within or near 
certain selected candidate genes and are associated 
with variations of human height at birth.
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